testosterone undecanoate
Selected indexed studies
- Testosterone Undecanoate-Schering AG. (Drugs R D, 2004) [PMID:15563244]
- Testosterone undecanoate in the treatment of male hypogonadism. (Expert Opin Pharmacother, 2010) [PMID:20642374]
- Injectable testosterone undecanoate for the treatment of hypogonadism. (Expert Opin Pharmacother, 2014) [PMID:25080279]
_Worker-drafted node — pending editorial review._
Connections
testosterone undecanoate is a side effect of
Sources
- Testosterone Undecanoate-Schering AG. (2004) pubmed
- Testosterone undecanoate in the treatment of male hypogonadism. (2010) pubmed
- Injectable testosterone undecanoate for the treatment of hypogonadism. (2014) pubmed
- Newer formulations of oral testosterone undecanoate: development and liver side effects. (2025) pubmed
- Testosterone undecanoate administration prevents declines in fat-free mass but not physical performance during simulated multi-stressor military operations. (2022) pubmed
- Long-term testosterone undecanoate replacement therapy: Impact of ethnicity. (2020) pubmed
- Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism. (2025) pubmed
- Long-term testosterone undecanoate treatment in the elderly testosterone deficient male: An observational cohort study. (2022) pubmed
- Occurrence of pulmonary oil microembolism (POME) with intramuscular testosterone undecanoate injection: literature review. (2023) pubmed
- A new oral testosterone undecanoate formulation. (2003) pubmed